TipRanks
Go Ultimate55% OFF

Procter & Gamble Hygiene & Health Care Ltd. (PGHH) AI Stock Analysis

IN:PGHH

Procter & Gamble Hygiene & Health Care Ltd.

(NSE:PGHH)

Select Model
Rating:69Neutral
Price Target:INR 7,446.00â–²(8.61% Upside)
Action:reiterated
Date:10/01/26

The score is driven primarily by strong financial performance (high margins, excellent balance-sheet strength, and solid cash conversion). This is offset by very weak technical momentum (below all major moving averages with negative MACD), while valuation is mixed—supported by a strong dividend yield but constrained by a relatively high P/E.

Positive Factors
Branded FMCG platformPGHH combines recognized feminine-hygiene and health-care brands with broad Indian distribution, supporting repeat purchases and product availability. This branded FMCG model can sustain customer familiarity and recurring demand while providing a durable base for merchandising and portfolio development.
Negative Factors
Recent revenue contractionThe latest annual revenue decline interrupts the prior expansion trend and raises questions about demand, pricing, product mix, or other business factors. Even with margins holding up, prolonged top-line weakness could limit operating leverage, brand investment capacity, and future earnings growth.

Procter & Gamble Hygiene & Health Care Ltd. (PGHH) vs. iShares MSCI India ETF (INDA)

-50%-40%-30%-20%-10%0%10%IN:PGHH-47.64%INDA-12.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
INR 222.39B
Dividend Yield
4.28%
Average Volume (3M)
1,228
Price to Earnings (P/E)
28.1
Beta (1Y)
0.42
Revenue Growth
-1.54%
EPS Growth
-4.58%
Country
India
Employees
439
Sector
General
Sector Strength
55
Industry
Household & Personal Products

Procter & Gamble Hygiene & Health Care Ltd. Business Overview & Revenue Model

Company Description

Established in 1964 and headquartered in Mumbai, India, Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of Procter & Gamble Overseas India BV. The company specializes in the manufacturing and worldwide distribution of brande...

How the Company Makes Money

PGHH primarily makes money by selling branded consumer products in India, generating revenue from the sale of its hygiene and health care portfolio to distributors, wholesalers, retailers, pharmacies, and other trade customers who then sell to end co...

Procter & Gamble Hygiene & Health Care Ltd. Financial Statement Overview

Summary

High-quality fundamentals supported by strong and improving profitability (net margin ~20%), very conservative leverage, and robust cash conversion (free cash flow closely tracks net income). The main concern is a sharp revenue contraction in the latest annual period and some volatility in cash flow growth.

Income Statement

83Very Positive

Balance Sheet

92Very Positive

Cash Flow

88Very Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue43.19B42.82B44.99B41.92B39.05B37.92B
Gross Profit26.99B24.73B25.48B23.52B20.24B20.30B
EBITDA11.78B11.97B12.11B10.23B9.09B8.54B
Net Income8.27B8.56B8.49B6.75B6.78B5.76B
Balance Sheet
Total Assets17.55B18.04B17.55B18.59B21.37B16.81B
Cash, Cash Equivalents and Short-Term Investments5.16B5.68B4.81B5.74B9.64B6.25B
Total Debt23.20M8.70M23.20M30.80M40.30M51.00M
Total Liabilities10.18B10.50B10.18B10.84B11.91B9.44B
Stockholders Equity7.37B7.53B7.37B7.75B9.46B7.38B
Cash Flow
Free Cash Flow6.08B8.75B5.63B4.26B7.81B5.23B
Operating Cash Flow6.76B9.24B6.18B4.71B8.26B5.73B
Investing Cash Flow-586.30M113.70M-586.30M10.60M-99.10M-268.50M
Financing Cash Flow-6.66B-8.45B-6.66B-8.62B-4.77B-5.69B

Procter & Gamble Hygiene & Health Care Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price6855.45

Price Trends

50DMA7336.92Negative
100DMA8044.18Negative
200DMA9294.68Negative

Market Momentum

MACD-128.69Negative
RSI39.63Neutral
STOCH36.23Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:PGHH, the sentiment is Negative. The current price of 6855.45 is below the 20-day moving average (MA) of 6912.91, below the 50-day MA of 7336.92, and below the 200-day MA of 9294.68, indicating a bearish trend. The MACD of -128.69 indicates Negative momentum. The RSI at 39.63 is Neutral, neither overbought nor oversold. The STOCH value of 36.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:PGHH.

Procter & Gamble Hygiene & Health Care Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:PGHH against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:MARICOIN:MARICO79OutperformINR 1.04T54.87―0.50%25.00%12.83%
IN:DABURIN:DABUR70OutperformINR 649.27B32.88―2.25%7.40%10.63%
IN:HINDUNILVRIN:HINDUNILVR69NeutralINR 4.38T29.09―2.20%6.41%38.32%
IN:PGHHIN:PGHH69NeutralINR 222.53B28.13―4.28%-1.54%-4.58%
IN:COLPALIN:COLPAL67NeutralINR 433.74B31.89―3.01%8.72%2.71%
IN:GODREJCPIN:GODREJCP65NeutralINR 834.22B42.32―2.44%12.02%8.49%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-40%-20%0%20%IN:PGHHIN:COLPALIN:DABURIN:GODREJCPIN:HINDUNILVRIN:MARICODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IN:PGHH and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:PGHHProcter & Gamble Hygiene & Health Care Ltd.6855.45-6237.03-47.64%
IN:COLPALColgate-Palmolive (India) Limited1594.70-580.27-26.68%
IN:DABURDabur India Limited366.00-128.29-25.95%
IN:GODREJCPGodrej Consumer Products Limited815.10-341.22-29.51%
IN:HINDUNILVRHindustan Unilever Limited1864.00-515.09-21.65%
IN:MARICOMarico Limited800.7582.6811.51%

Procter & Gamble Hygiene & Health Care Ltd. Corporate Events

P&G Hygiene Resets Dividend Record Date Ahead of September AGM

Aug 7, 2026

Procter & Gamble Hygiene and Health Care Limited has revised the record date for determining shareholders eligible for dividend and participation at its 62nd Annual General Meeting to 1 September 2026. The AGM will be held on 8 September 2026, an...

P&G Hygiene Sets AGM and Dividend Timeline for September 2026

Aug 7, 2026

Procter & Gamble Hygiene and Health Care Ltd. has scheduled its 62nd Annual General Meeting for September 8, 2026, as disclosed to both BSE and the National Stock Exchange. The company has set September 1, 2026 as the record date for determining...

P&G Hygiene and Health Care names new Sales Head as leadership shifts to Korea role

Jul 1, 2026

Procter & Gamble Hygiene and Health Care Ltd. announced a leadership transition in its sales function, with seasoned executive Gopalakrishnan Kalianna set to become Sales Head effective August 1, 2026. Kalianna brings over two decades of experien...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 01, 2026